Is the recent market turbulence creating buying opportunities? Michelle Martin looks at Bank of America’s call on Nvidia and other stocks it believes are now attractively priced, as bond-market warning signals loom over a new trading week. Plus, the battle for the obesity-drug market intensifies as Novo Nordisk searches for its next growth chapter against Eli Lilly, while another pharma stock rockets on an injectables deal with the Wegovy maker. In Up or Down, why has Microsoft climbed back to its highest close of 2026, why did the launch of the long-awaited Tesla Semi fail to excite investors, and what are insider buying and a bigger share-buyback programme telling us about Singapore-listed Nam Cheong and Seatrium? And in the Last Word: Avengers: Endgame returns to cinemas - and seven years later, Earth's mightiest heroes are back on top at the box office.See omnystudio.com/listener for privacy information.

Is the recent market turbulence creating buying opportunities? Michelle Martin looks at Bank of America&rsquo;s call on Nvidia and other stocks it believes are now attractively priced, as bond-market warning signals loom over a new trading week. Plus, the battle for the obesity-drug market intensifies as&nbsp;Novo Nordisk&nbsp;searches for its next growth chapter against&nbsp;Eli Lilly, while another pharma stock rockets on an injectables deal with the Wegovy maker. In&nbsp;Up or Down, why has&nbsp;Microsoft&nbsp;climbed back to its highest close of 2026, why did the launch of the long-awaited&nbsp;Tesla Semi&nbsp;fail to excite investors, and what are insider buying and a bigger share-buyback programme telling us about Singapore-listed&nbsp;Nam Cheong and Seatrium? And in the Last Word:&nbsp;Avengers: Endgame returns to cinemas - and seven years later, Earth's mightiest heroes are back on top at the box office.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Market View: Nvidia on Sale? Novo vs Lilly, Microsoft’s Comeback and Tesla’s Semi Problem